Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.
Ansari AW, Jayakumar MN, Ahmad F, Venkatachalam T, Salameh L, Unnikannan H, Raheed T, Mohammed AK, Mahboub B, Al-Ramadi BK, Hamid Q, Steinhoff M, Hamoudi R.
Ansari AW, et al. Among authors: jayakumar mn.
Front Immunol. 2024 Aug 15;15:1447625. doi: 10.3389/fimmu.2024.1447625. eCollection 2024.
Front Immunol. 2024.
PMID: 39211048
Free PMC article.